Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Use of Digital Genetic Counselor (DGC) for BRCA1/2 Mutation Carrier Testing

NCT04038905 is registered in ClinicalTrials.gov with Igentify Ltd as lead sponsor.

NCT NCT04038905
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04038905 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Use of Digital Genetic Counselor (DGC) for BRCA1/2 Mutation Carrier Testing
Lead sponsor
Igentify Ltd
Phase
Observational
Overall status
Unknown status
Start date
April 1, 2020
Completion date
April 30, 2022
Enrollment
300 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

brca mutations